ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership10,045 shares
Latest Disclosed Value $ 223,596
Advisor Group Holdings, Inc. reports 1.28% increase in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 10,045 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $223,596 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 9,918 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of 1.28% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,045 127 1.28 224 -15.53 0.0002
2026-02-17 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,918 -7,132 -41.83 265 -32.99 0.0004
2025-11-14 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 17,050 7,789 84.11 394 97.99 0.0006
2025-09-04 2025-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 9,261 202 2.23 200 32.67 0.0004
2025-08-13 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,360 -4,699 86 0.0001
2025-05-12 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,059 2,914 47.42 150 41.51 0.0003
2025-06-06 2024-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 6,145 -759 -10.99 106 0.00 0.0002
2025-02-07 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,020 116 112 0.0003
2024-11-13 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 6,904 696 11.21 106 6.00 0.0002
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 6,208 -2,615 -29.64 100 -38.27 0.0002
2024-05-10 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 8,823 -20,341 -69.75 162 -82.26 0.0004
2024-02-12 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 29,164 -71,142 -70.92 913 -56.32 0.0016
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 100,306 68,397 214.35 2,090 172.85 0.0031
2023-08-21 2023-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 31,909 7,234 29.32 767 66.16 0.0014
2023-08-10 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 31,909 7,234 767 0.0002
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 24,675 2,689 12.23 461 31.71 0.0009
2023-02-10 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,986 -998 -4.34 350 -7.16 0.0007
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,984 109 0.48 377 17.08 0.0009
2022-08-10 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,875 -800 -3.38 322 -33.20 0.0007
2022-05-04 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 23,675 -2,810 -10.61 482 -22.63 0.0009
2022-02-03 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,485 2,399 9.96 623 54.59 0.0012
2021-11-05 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 24,086 -1,593 -6.20 403 -36.03 0.0008
2021-08-02 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 25,679 -1,267 -4.70 630 -9.61 0.0014
2021-05-13 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 26,946 -2,806 -9.43 697 -56.14 0.0017
2021-02-10 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 29,752 -1,216 -3.93 1,589 20.29 0.0042
2020-11-12 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 30,968 6,593 27.05 1,321 11.95 0.0040
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 24,375 545 2.29 1,180 16.49 0.0040
2020-05-18 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 23,830 23,830 1,013 0.0041
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.